INTRODUCTION
Over 80% of children with cancer will become long-term survivors.
1,2 Consequently, there are over 400,000 childhood cancer survivors (CCS) in the United States, many of whom will experience chronic morbidity as a result of their treatment. 3 Research and program development has focused on the physical sequelae of cancer, with less attention to its psychological impacts. Because mental illness often has its first onset during adolescence, 4 CCS may be vulnerable to the trauma of their cancer experience and the impact of therapy on their mental health. Although some studies have reported higher rates of suicidal ideation, post-traumatic stress disorder, and symptoms of depression and anxiety compared with siblings, [5] [6] [7] [8] [9] [10] others have not indicated an elevated risk for adverse outcomes. [11] [12] [13] [14] Several studies have demonstrated superior mental health in CCS compared with controls. [15] [16] [17] Some of the inconsistencies in these observations may be because of the relative advantages and limitations of different methods for assessing mental health outcomes. For example, large cohort studies that use self-report questionnaires often have a high number of nonresponders, 5, 18 some of whom may be at elevated risk of poor mental health. 19 Selfreport may not accurately reflect the true incidence of psychiatric symptoms because it is susceptible to social desirability response bias. 20, 21 Research linking cancer survivors to their health care administrative records can provide objective data on whole populations, but such studies use contact with the health care system or consumption of psychotropic medication as a surrogate for poor mental health outcomes and thus do not directly assess mental health. One such populationbased study from Denmark demonstrated that, among 7085 CCS, there was an elevated risk of hospital contact for a mental disorder compared with their siblings. 22 However, studies like this may be hindered by incomplete treatment data or an inability to capture outpatient visits or care from nonmedical providers of mental health care, such as psychologists, social workers, and complementary or alternative medicine care providers. A complete understanding of mental health outcomes in CCS likely requires data from multiple types of studies, including administrative data that capture both inpatient and outpatient health care use.
Canadian health care is delivered through a provincial, single-payer, universal insurance system. Canada's most populous province, Ontario, maintains a registry of all children treated for cancer at the province's 5 tertiary pediatric centers. This registry captures detailed diagnostic and treatment data. These can be linked to health care administrative records maintained by the province's health care system, facilitating the capture of all outpatient and hospital encounters with the health care system for a mental health complaint in this population-based cohort of CCS to assess the risk for adverse mental health outcomes.
MATERIALS AND METHODS

Study Population
After obtaining Research Ethics Board approval, we identified eligible survivors using the Pediatric Oncology Group of Ontario's Networked Information System (POGONIS), which has captured all pediatric (ages 0-17.9 years at diagnosis) cancers treated at any of Ontario's 5 pediatric cancer centers since 1985. Approximately 96% of children ages 0 to 14.9 years and 46% of adolescents ages 15 to 17.9 years receive cancer care in a pediatric center and thus are documented in POGONIS. 23 Individuals in POGONIS were considered eligible for this analysis if they had been diagnosed with a first cancer between January 1, 1987 and December 31, 2008; had survived greater than 5 years since their last pediatric cancer event (the latest of their initial diagnosis or a relapse or subsequent malignant neoplasm [SMN] before age 18 years); had reached age 16 years (the age at which administrative data can be used to capture all types of mental health visits) before the end of the follow-up period (December 31, 2013); and had provided at least 1 year of follow-up after reaching 5 years from their last pediatric cancer event. For each survivor, we randomly selected 2 to 5 controls from the general population matched by birth year and month, sex, and residential location (using postal code) at the time of their cancer diagnosis.
Outcome Definition
We deterministically linked survivors and controls to administrative health databases held at the Institute for Clinical Evaluative Sciences using their unique health card number, which was encoded to ensure anonymity. The administrative health databases accessed were the Registered Persons Database, the Ontario Health Insurance Plan Claims Database (OHIP), the National Ambulatory Care Reporting System, the Canadian Institutes of Health Information Discharge Abstract Database the Ontario Mental Health Reporting System (OMHRS), the Office of the Registrar General-Deaths, and the Ontario Cancer Registry.
Because the OMHRS database only captures psychiatric admissions in patients aged 16 years or older, mental health visits were documented starting at an index date (the later of age 16 years or 5 years after the last pediatric cancer event) until the earliest of the end of study followup, relapse or an SMN during adulthood, or death. Controls were assigned the same index date and follow-up period as their corresponding survivor. Visits to a family physician for a mental health complaint and any visit to a psychiatrist were identified from OHIP physician billings using a validated algorithm. 24 Emergency department (ED) visits for a mental health indication were identified using data from OHIP and the National Ambulatory Care Reporting System, and hospitalizations were obtained from the Canadian Institutes of Health Information Discharge Abstract Database and OMHRS. Suicides were identified from the cause of death documented in the Office of the Registrar General-Deaths. A mental health visit was defined as a visit to a family physician, psychiatrist, or ED or a hospitalization. A severe mental health event was defined as an ED visit, hospitalization, or suicide. ED visits and hospitalizations contributed to both the mental health visits and severe mental health event outcomes. If more than 1 severe event occurred within 24 hours, then the event was classified as the most severe of an ED visit, a hospitalization, or a suicide. To determine whether any broad groups of psychiatric diagnoses (eg, anxiety or mood/affective disorders) contributed disproportionately to severe events, we subclassified ED visits and hospitalizations into the following diagnostic subcategories using International Statistical Classification of Diseases-10th Revision and Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition codes (Supporting Table 1 ; see online supporting information): substanceabuse, psychotic disorders, mood/affective disorders, anxiety disorders, and selected disorders of adult personality and behavior. 25 Original Article 
Definition of Covariates
Variables that were considered potential predictors of outcome included sex, age at diagnosis, income quintile (using census data to assign an average neighborhood household income to the postal code at diagnosis), cancer diagnosis, 26 and the occurrence of a relapse or SMN before age 18 years. Receipt of chemotherapy agents with plausible central nervous system (CNS) effects also was considered; we recorded exposure to corticosteroids used as chemotherapy agents and high-dose methotrexate (1 g/m 2 per dose). We captured receipt of alkylating agents, 27 cranial radiation, and hematopoietic stem cell transplantation (HSCT). The overall intensity of treatment was classified using the Intensity of Treatment Rating Scale. 28 We defined 3 treatment eras based on year of diagnosis.
Statistical Analysis
We generated descriptive statistics to compare the distribution of baseline characteristics between survivors and controls ( Table 1) . Frequencies and percentages summarized categorical variables, and medians and minimummaximum ranges summarized continuous variables. We calculated the crude rate of visits by survivors and controls as well as the crude relative rate.
An individual-level analysis modeled the association between survivorship and the rate of mental health visits. Because visits can occur numerous times for each individual over the course of observation, Andersen-Gill recurrent event multivariable regression models were used, 29, 30 adjusting for prior mental health visits. A robust sandwich variance estimation approach accounted for the matched design. The Anderson-Gill model also was used to determine predictors of the rate of mental health visits only among survivors. To illustrate the outcome rate over time, nonparametric analyses were performed by estimating the mean cumulative functions, 31, 32 which provided an estimate of the mean cumulative number of mental health visits over time. Cox proportional hazard regression was used to model the time to a first severe mental health event, and the cumulative incidence function approach was used to determine the risk of having a severe mental health event. We decided, a priori, to include age, sex, and income quintile in both multivariable regression models in addition to any variables in the univariate analyses that were significant at P < .05. All analyses were performed using SAS statistical software (version 9.3; SAS Inc, Cary, NC).
RESULTS
Of 7884 children who received treatment between 1987 and 2008, 4117 were eligible for inclusion ( Fig. 1 ). Of these, 3992 children (95.7%) could be matched to 5 population controls, and the remainder could be matched to 2 to 4 controls ( Table 1 ). Both groups were followed for a median of 7.5 years from their index date (minimummaximum range, 1.0-21.9 years). Table 2 presents the crude rates of mental health care visits to family physicians, psychiatrists, and all visits combined. Survivors had a higher rate of visits to family physicians (unadjusted rate ratio [RR], 1.32; 95% confidence interval [CI], 1.25-1.39) and psychiatrists (unadjusted RR, 1.56; 95% CI, 1.41-1.72). After adjusting for sex, income quintile, age category and a history of prior events, survivors had an elevated rate of any mental health care visit (family physician, psychiatrist, ED, or hospitalization) compared with controls (RR, 1.34; 95% CI, 1.12-1.52) (Fig. 2A) . Although survivors individually did not have an elevated risk for ED visits, hospitalizations, or suicide (Table  3) , their risk for experiencing any severe mental health event was significantly increased. After adjusting for sex, income quintile, and age category, the hazard ratio (HR) for a severe event in survivors versus controls was 1.13 (95% CI, 1.00-1.28; P 5 .045) (Fig. 2B) . Within subcategories of psychiatric diagnoses, anxiety disorders were the most prevalent among both groups (Table 4) . However, the only category in which survivors were at significantly greater risk was psychotic disorders (HR, 1.78; 95% CI, 1.09-2.89). Table 5 displays the recurrent event regression analysis for the rate of mental health visits among survivors. In the multivariable model, survivors who were female and aged 15 years or older at diagnosis had a significantly higher rate of mental health visits than males or those who were younger at diagnosis. A comparison of the cumulative function of visits by time from the index date, stratified for age group at diagnosis, is illustrated in Figure  2C . None of the variables income quintile at diagnosis, cancer type, relapse or SMN during childhood, cranial radiation, HSCT, high-dose methotrexate, or treatment era were associated with the rate of mental health visits.
We also assessed the risk factors for a severe event in survivors (Table 6) . Survivors who had received cranial radiation had a reduced risk of a severe event compared with those who did not. Survivors who were in the highest income quintile at diagnosis were significantly less likely to experience a severe event than those in the lowest quintile. Survivors who were diagnosed at ages 5 to 9, 10 to 14, or 15 years were less likely than those diagnosed at ages 0 to 4 years to experience a severe event, although this difference was only statistically significant in the groups ages 5 to 9 and 10 to 14 years (Fig. 2D) . Among those survivors who were ages 0 to 4 years at diagnosis, 131 had a severe event during study follow-up. By age 28 years, the cumulative incidence of a severe event in this subgroup was 16.3% (95% CI, 13.2%-19.8%). The most frequent diagnostic subcategories were anxiety (41.2%), substance abuse (34.4%), and mood/affective disorders (24.4%). Psychotic disorders and personality disorders occurred in less than 10% of these survivors. Among survivors who were diagnosed at ages 0 to 4 years, only being in the highest income quintile at diagnosis was associated with a reduced risk of a severe event (Table 7) .
DISCUSSION
In this provincial cohort of over 4000 CCS, survivors had a 34% higher rate of medical visits for a mental health complaint than the general population. More than 40% of survivors had at least 1 visit, and 90% of encounters were with family physicians and psychiatrists. Visits were significantly more frequent among females and survivors of adolescent cancers. Studies have demonstrated that adolescents are vulnerable to psychological challenges after a cancer diagnosis. Counseling and psychological support are among the most common needs expressed by these survivors, 33 who often report symptoms of posttraumatic stress, anxiety and depression, and fears of cancer recurrence. 34 Many adolescents who require mental health services after cancer do not receive them, 35, 36 suggesting that the documented rate of visits underestimates their true burden of psychological morbidity.
Although ED visits and hospitalizations were less common than visits to a family physician or psychiatrist, survivors had a 13% increase in their risk for a severe event. Suicides were rare, a finding that mirrors other studies indicating that, although suicidal ideation might be more frequent in survivors, 6 suicide is not. 37 Our findings are consistent with those from the Danish population-based cohort study, which demonstrated a 38% elevation in the risk for contact with hospital psychiatric departments. 22 In that study, children who were Charts illustrate (A) the average cumulative number of mental health care visits among survivors and controls as a function of attained age, (B) the cumulative incidence of a first severe event (emergency department visit, hospitalization, or suicide) in survivors versus controls as a function of attained age, (C) the average cumulative number of mental health care visits among survivors over time stratified by age group at diagnosis, and (D) the risk of a severe event (emergency department visit, hospitalization, or suicide) in survivors according to attained age stratified by age group at diagnosis. Shaded areas in A and B represent 95% confidence intervals around estimates. younger than 10 years at diagnosis were at a particularly elevated risk of hospital contact. Similarly, we demonstrated that patients diagnosed at ages 0 to 4 years were one-third more likely than older children to experience a severe psychiatric event later in life. It is intriguing to consider whether a specific therapeutic exposure or the overall intensity of cancer treatment might impact the young developing brain in a manner that predisposes to the development of psychiatric disease later in life. We did not identify any such exposure: the risk of severe morbidity was not a consequence of cancer type, treatment intensity, or exposure to chemotherapy with a possible CNS impact. In fact, cranial radiation appeared to have a protective effect in the overall cohort, an unexpected finding that may be because of residual confounding (clinicians are less likely to subject younger children to cranial radiation) or could be spurious. Nonbiologic causes of the risk for severe psychiatric events in survivors of cancer at young ages could be related to the impact of the cancer diagnosis on parental behavior and the considerable stress of a life-threatening illness on the child. Limited studies have indicated that the disruption of parenting practices during and after cancer therapy can impact the emotional health of their children. Parents of young children with leukemia reportedly display lax parenting practices and overprotection, which have been associated with subsequent childhood emotional and behavioral difficulties. 38, 39 Other studies have demonstrated that parenting stress and perceived childhood vulnerability negatively impact adjustment in their children. Whether such parenting practices have a long-term impact on mental health has not been established and should be a focus of future research. In the general population, adverse childhood experiences (which are defined as stressful or traumatic childhood events) have been linked to the development of mental health disorders in adulthood. 40 Limited literature regarding the impact of a life-threatening childhood illness on subsequent mental health suggests that illnesses such as cancer might impact psychiatric outcomes in some children in a manner analogous to other adverse childhood experiences. 41 Our findings about the differential impact of age on the rate of mental health care visits (which were more frequent in patients who received treatment during adolescence) and severe mental health events (which were more common in those who received treatment during early childhood) suggest that outcomes in CCS should be conceptualized as 2 separate constructs. Conflating these may mask at-risk populations and potential mechanisms. Neither construct was associated with specific cancer diagnoses, treatment exposures, or the intensity of therapy; rather, both were associated with demographic factors such as age, sex, and socioeconomic status, suggesting that it is the cancer experience and not the direct impact of a specific therapy that influenced outcomes. The impact of sex and socioeconomic status mirror the risk factors for mental health disorders in the general population, in which it has been demonstrated that females are at elevated risk for mood and anxiety disorders 42, 43 and are more likely to access the mental health care system. Lower socioeconomic status also has been associated with an elevated risk for mental health disorders, 44, 45 but it is unclear whether this is a cause or a consequence of these outcomes in the general population. 46 In our analysis, being in the highest socioeconomic stratum at the time of cancer diagnosis protected against severe psychiatric morbidity later in life.
Depression and anxiety are among the more common psychiatric outcomes observed in CCS. A population-based study in British Columbia demonstrated a 20% increased use of antidepressants in survivors compared with the general population. 47 The Danish group observed an elevated risk for antidepressant prescription, particularly in children who received more intensive therapies like HSCT. 48 In contrast, the North American Childhood Cancer Survivor Study reported that survivors were more likely to use anxiolytic, sedative, and hypnotic medications but were no more likely to use antidepressants. 5 Survivors in our cohort were not at an elevated risk for ED visits or hospitalizations for mood/affective disorders or anxiety disorders, although it is likely that many patients with these diagnoses would be treated in an outpatient setting except in cases of extreme distress. To our knowledge, we are the first group to demonstrate a small but statistically significant elevated risk of psychotic disorders, but this requires confirmation in other cohorts.
Our study has numerous strengths. It assesses mental health care in a large, well characterized, population-based cohort of CCS and is not limited by the biases inherent to studies that rely on self-report or clinic-based assessments in selected subsets of survivors. Unlike the Danish study, we were able to assess the impact of specific cancer therapies. These did not modify the risk for adverse outcomes, which is an important and novel finding. However, our findings should be interpreted in the context of several limitations.
First, although it has been demonstrated that physician diagnoses in health care administrative claims are a reliable measure of mental illness, 49 the current study could not capture patients who had developed a mental health problem but did not access mental health care or those who sought care from a practitioner who did not bill the provincial health care system, such as a psychologist or social worker. However, access to nonphysician mental health professionals is quite limited within Ontario's publicly funded system and is accessible based on the existence of private insurance coverage or an ability to pay. Consequently, most of the contacts for mental health services are captured in the freely available access to family physicians and psychiatrists, because universal coverage provides access to these providers without requiring copayment.
Second, we could only subclassify the psychiatric indication for visits to an ED and hospitalizations. There is no validated mechanism for determining the reason for a mental health visit to a family physician or psychiatrist; therefore, the overall prevalence of specific mental health diagnoses in the survivor population cannot be determined.
Third, we could not directly assess the relation between physical late effects and poor mental health outcomes and thus cannot determine whether the increased risk of adverse mental health outcomes is related to poor physical health. The absence of a relation between specific treatments or the intensity of treatment as a whole and the risk of adverse mental health outcomes suggests that mechanisms other than the acute toxicities of cancer therapy may modulate mental health outcomes; however, direct assessment of physical health outcomes would be needed to definitively rule out chronic physical health conditions as a risk factor for poor mental health.
Finally, our cohort only included about one-half of the adolescents (ages 15-17.9 years) who received treatment for cancer, because the remaining adolescents were treated in adult centers. Medical and psychosocial supports offered to adolescents in a pediatric hospital often differ from those offered in an adult center, and the distribution of diagnoses in adolescents who use pediatric centers differs from that of diagnoses in adolescents who use adult centers in Ontario (eg, leukemia and lymphoma more likely to be treated in a pediatric center, whereas melanoma and thyroid cancer are more likely to be treated in an adult center; unpublished data). Consequently, care should be taken in generalizing our findings to adolescents who receive treatment in adult hospitals.
In summary, CCS demonstrated an increased rate of mental health visits, particularly outpatient visits to family physicians and psychiatrists. ED visits and hospitalizations were less common but still more likely in survivors than in the general population. Risk was driven by demographic factors, not treatment intensity or therapeutic exposures. Most striking was the observation that, although adolescents have a higher risk for mental health visits in general, survivors of cancer during early childhood are most at risk for severe mental health outcomes. Future work should focus on screening for distress and providing mental health resources to survivors of adolescent cancer and on further exploring the mechanism for severe psychiatric outcomes in children who receive treatment for cancer at young ages.
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